BEAM THERAPEUTICS INC (BEAM) Stock Analyst Earnings Estimates
NASDAQ:BEAM - Nasdaq - US07373V1052 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 60.92M 17.52% | 377.709M 520.01% | 63.518M -83.18% | 53.403M -15.92% | 62.58M 17.18% | 67.655M 8.11% | 130.39M 92.73% | 461.89M 254.24% | 894.26M 93.61% | 957.23M 7.04% | 1.326B 38.52% | |
| EBITDA YoY % growth | -324.33M 15.76% | -156.473M 51.76% | -393.643M -151.57% | -473.445M -20.27% | -506.428M -6.97% | -554.654M -9.52% | -249.798M 54.96% | -207.57M 16.90% | -137.7M 33.66% | N/A | N/A | |
| EBIT YoY % growth | -338.48M 13.76% | -176.485M 47.86% | -415.568M -135.47% | -476.745M -14.72% | -504.776M -5.88% | -541.353M -7.25% | -552.15M -1.99% | -386.128M 30.07% | -102.723M 73.40% | 1.534M 101.49% | 170.68M 11,026.47% | |
| Operating Margin | -555.61% | -46.73% | -654.25% | -892.73% | -806.61% | -800.17% | -423.46% | -83.60% | -11.49% | 0.16% | 12.87% | |
| EPS YoY % growth | -4.13 30.47% | -1.90 54.00% | -4.58 -141.05% | -4.68 -2.13% | -4.72 -0.92% | -4.85 -2.76% | -3.76 22.59% | -2.65 29.49% | -1.61 39.37% | -0.30 81.15% | 0.65 315.71% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.08 7.68% | -1.12 -2.84% | -1.20 2.92% | -1.33 -32.86% | -1.32 -21.95% | -1.32 -17.65% | -1.46 -21.59% | -1.41 -6.49% | -1.38 -4.93% | -1.28 3.17% |
| Revenue Q2Q % growth | 14.025M -1.71% | 14.322M -52.37% | 15.81M 111.65% | 18.998M 124.40% | 19.253M 37.28% | 19.253M 34.43% | 20.4M 29.03% | 20.4M 7.38% | 20.4M 5.96% | 31.977M 66.09% |
| EBITDA Q2Q % growth | -113.387M -25.96% | -117.175M -50.01% | -85.884M 24.50% | -86.598M 20.61% | -87.312M 23.00% | -88.23M 24.70% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -109.985M -3.27% | -112.941M -12.90% | -111.588M 6.45% | -112.965M 5.98% | -114.342M -3.96% | -115.821M -2.55% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.00 9.91% | -1.13 | 0.13 | 11.65% |
| Q1 2025 Q2Q % growth | -1.24 -2.48% | -1.23 | -0.01 | -0.76% |
| Q4 2024 Q2Q % growth | -1.09 -163.01% | -1.23 | 0.14 | 11.25% |
| Q3 2024 Q2Q % growth | -1.17 4.10% | -1.18 | 0.01 | 0.76% |
| Q2 2024 Q2Q % growth | -1.11 -2.78% | -1.15 | 0.04 | 3.51% |
| Q1 2024 Q2Q % growth | -1.21 9.02% | -1.45 | 0.24 | 16.31% |
| Q4 2023 Q2Q % growth | 1.73 420.37% | -1.03 | 2.76 | 267.72% |
| Q3 2023 Q2Q % growth | -1.22 21.79% | -1.39 | 0.17 | 12.16% |
| Q2 2023 Q2Q % growth | -1.08 -5.88% | -1.45 | 0.37 | 25.68% |
| Q1 2023 Q2Q % growth | -1.33 -31.68% | -1.37 | 0.04 | 2.85% |
| Q4 2022 Q2Q % growth | -0.54 43.16% | -1.35 | 0.81 | 60.13% |
| Q3 2022 Q2Q % growth | -1.56 -271.43% | -1.34 | -0.22 | -16.50% |
| Q2 2022 Q2Q % growth | -1.02 17.07% | -1.10 | 0.08 | 7.25% |
| Q1 2022 Q2Q % growth | -1.01 69.76% | -1.35 | 0.34 | 24.99% |
| Q4 2021 Q2Q % growth | -0.95 43.79% | -1.05 | 0.10 | 9.38% |
| Q3 2021 Q2Q % growth | -0.42 39.13% | -0.75 | 0.33 | 44.10% |
| Q2 2021 Q2Q % growth | -1.23 -78.26% | -0.66 | -0.57 | -86.60% |
| Q1 2021 Q2Q % growth | -3.34 -224.27% | -0.75 | -2.59 | -343.25% |
| Q4 2020 Q2Q % growth | -1.69 62.19% | -0.68 | -1.01 | -146.77% |
| Q3 2020 Q2Q % growth | -0.69 | -0.57 | -0.12 | -21.67% |
| Q2 2020 Q2Q % growth | -0.69 | -0.54 | -0.15 | -28.12% |
| Q1 2020 Q2Q % growth | -1.03 | -0.52 | -0.51 | -99.96% |
| Q4 2019 Q2Q % growth | -4.47 | -0.53 | -3.94 | -737.40% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 8.466M -28.08% | 13.836M | -5.37M | -38.81% |
| Q1 2025 Q2Q % growth | 7.47M 0.81% | 15.164M | -7.694M | -50.74% |
| Q4 2024 Q2Q % growth | 30.067M -90.49% | 17.269M | 12.798M | 74.11% |
| Q3 2024 Q2Q % growth | 14.269M -17.01% | 14.789M | -520K | -3.52% |
| Q2 2024 Q2Q % growth | 11.772M -41.48% | 14.466M | -2.694M | -18.62% |
| Q1 2024 Q2Q % growth | 7.41M -69.39% | 17.307M | -9.897M | -57.18% |
| Q4 2023 Q2Q % growth | 316.192M 1,477.80% | 19.046M | 297.146M | 1,560.15% |
| Q3 2023 Q2Q % growth | 17.193M 8.82% | 17.458M | -265K | -1.52% |
| Q2 2023 Q2Q % growth | 20.116M 20.82% | 18.413M | 1.703M | 9.25% |
| Q1 2023 Q2Q % growth | 24.208M 187.16% | 14.359M | 9.849M | 68.59% |
| Q4 2022 Q2Q % growth | 20.04M -60.76% | 12.989M | 7.051M | 54.28% |
| Q3 2022 Q2Q % growth | 15.8M 1,978.95% | 7.294M | 8.506M | 116.62% |
| Q2 2022 Q2Q % growth | 16.65M 166,400.00% | 8.558M | 8.092M | 94.55% |
| Q1 2022 Q2Q % growth | 8.43M 84,200.00% | 6.024M | 2.406M | 39.94% |
| Q4 2021 Q2Q % growth | 51.07M 510,600.00% | 2.36M | 48.71M | 2,063.98% |
| Q3 2021 Q2Q % growth | 760K 7,500.00% | 7.335M | -6.575M | -89.64% |
| Q2 2021 Q2Q % growth | 10K | 2.04K | 7.96K | 390.20% |
| Q1 2021 Q2Q % growth | 10K | 1.744K | 8.256K | 473.33% |
| Q4 2020 Q2Q % growth | 10K | 2.04K | 7.96K | 390.20% |
| Q3 2020 Q2Q % growth | 10K | 1.53K | 8.47K | 553.59% |
| Q2 2020 Q2Q % growth | 10K | 1.53K | 8.47K | 553.59% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 6.68% | 0% | 4.53% |
| Revenue | 0% | -13.69% | 0% | -0.42% |